search
Back to results

Reducing Cardiometabolic Risk and Promoting Functional Health in Older Adults With Obesity and Prediabetes (Sustain-DPP)

Primary Purpose

Obesity, PreDiabetes, Aging

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
DPP Intensive: 30-minute calls
DPP Support: 15-minute calls
Sponsored by
University of Pittsburgh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Obesity focused on measuring Intervention, Prevention, Weight Management, Physical Activity, Physical Function

Eligibility Criteria

60 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Men and women
  • Ages 60 and older
  • Body mass index (BMI) >= 27 kg/m2
  • Prediabetes defined as Hemoglobin (HbA1c) >= 5.7 % and <= 6.4 % or fasting glucose of >= 100 mg/dL and less than 126 mg/dL (at either screening or baseline visit)
  • Access to a telephone (for group calls) and to video-player or computer with Internet (to watch session videos and activity videos)
  • Able to travel to one of the community clinics in Southwestern Pennsylvania to participate in the first four in-person intervention sessions and five health assessments at 0, 6, 12, 18, and 24 months
  • Has health care provider permission to participate

Exclusion Criteria:

  • Currently diagnosed with diabetes (defined as HbA1c of >= 6.5% at either screening or baseline visit)
  • Currently taking glucose lowering medications or weight loss medications
  • Weight loss of 9 pounds or more in the last six months
  • History of bariatric surgery within the last 2 years
  • Permanently confined to wheelchair
  • Significant cognitive or psychiatric disability that would preclude participation in normal community-based educational activities

Sites / Locations

  • Univ. Pittsburgh School of Medicine-Dept. Psychiatry

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Placebo Comparator

Arm Label

DPP Plus: 30-minute calls

DPP Minimal: 15-minute calls

Arm Description

Following the 6-month, 16-session, DPP core program, 30-minute group telephone calls will be implemented. Structured behavioral DPP maintenance sessions with a healthy aging focus occur once-per-month from months 7 to 12, and every-two-months from months 13 to 24.

Following the 6-month, 16-session, DPP core program, 15-minute group telephone calls will be implemented. Social-support sessions occur once-per-month from months 7 to 12, and every-two-months from months 13 to 24.

Outcomes

Primary Outcome Measures

Change in bodyweight
percent weight loss

Secondary Outcome Measures

Change in waist circumference
centimeters
Change in waist circumference
centimeters
Change in fasting glucose
mg/dL
Change in fasting glucose
mg/dL
Change in fasting insulin
pmol/L
Change in fasting insulin
pmol/L
Change in hemoglobin (HbA1c)
HbA1c percent
Change in hemoglobin (HbA1c)
HbA1c percent
Change in total cholesterol
mg/dL
Change in total cholesterol
mg/dL
Change in high-density lipoprotein (HDL)
mg/dL
Change in high-density lipoprotein (HDL)
mg/dL
Change in low-density lipoprotein (LDL)
mg/dL
Change in low-density lipoprotein (LDL)
mg/dL
Change in triglycerides
mg/dL
Change in triglycerides
mg/dL
Change in systolic blood pressure (SBP)
mmHg
Change in systolic blood pressure (SBP)
mmHg
Change in diastolic blood pressure (DBP)
mmHg
Change in diastolic blood pressure (DBP)
mmHg
Change in physical function
Short Physical Performance Battery total score (0-12) includes three function tests (each scored 0-4) and summed. The subtests are (1) gait speed measured in meters/second on a 4-meter walk route; 3 progressive standing balance tests; 5 chair stands. Higher score indicates better physical function.
Change in physical function
Short Physical Performance Battery total score (0-12) includes three function tests (each scored 0-4) and summed. The subtests are (1) gait speed measured in meters/second on a 4-meter walk route; 3 progressive standing balance tests; 5 chair stands. Higher score indicates better physical function.

Full Information

First Posted
March 26, 2018
Last Updated
June 2, 2023
Sponsor
University of Pittsburgh
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
search

1. Study Identification

Unique Protocol Identification Number
NCT03500640
Brief Title
Reducing Cardiometabolic Risk and Promoting Functional Health in Older Adults With Obesity and Prediabetes
Acronym
Sustain-DPP
Official Title
Reducing Cardiometabolic Risk and Promoting Functional Health in Community-based Elders With Obesity and Pre-diabetes: Evaluating Sustainable DPP Follow-up Strategies
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Completed
Study Start Date
March 27, 2018 (Actual)
Primary Completion Date
January 27, 2023 (Actual)
Study Completion Date
May 1, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Pittsburgh
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Obesity and pre-diabetes threatens the overall health and functional independence of older adults but lifestyle weight management for diabetes prevention, soon to be reimbursed by Medicare, can reduce this burden. The current 24-month study will enroll adults, ages 60 and older, through senior community centers and research registries. The investigators will study how two long term weight loss maintenance programs, both using group telephone sessions to support health behavior change, impact meaningful health outcomes. If successful, this project will provide a sustainable intervention model for healthy aging services that can benefit older adults and society.
Detailed Description
The confluence of obesity and pre-diabetes in older adults increases the risk of diabetes, and accelerates functional decline, chronic disease, disability, and death. More research is needed to refine and extend preventive interventions to reduce burden for vulnerable individuals and society. For over a decade efficacious 6- and 12-month Diabetes Prevention Program (DPP) lifestyle interventions have been translated successfully and shown positive impact. However, efforts to develop and evaluate scalable programs conforming to current guidelines for longer term DPP interventions (up to 24 months), which are consistent with a chronic care model, and help a greater proportion of enrollees sustain the recommended weight loss target of ≥ 5% are lacking. The scientific premise is that evaluation of translational DPP interventions, which has centered largely on strategies for weight loss induction, must be extended to include scalable longer-term interventions that show meaningful weight, cardiometabolic and functional health benefits for vulnerable older adults in community-based settings. A previous DPP-based study from this group of investigators documented the utility of telephone follow-up after 12-weeks of DPP weight loss induction and demonstrated that 63% of the 65-80-year-old volunteer sample with obesity and other risk factors were able to sustain ≥ 5% weight loss at 12-months. Despite good evidence that longer duration lifestyle interventions yield better outcomes (reflected in the latest Medicare ruling) there are no translational studies of 24-month long DPP-based interventions for older adults exclusively. The investigators will recruit participants from a broad array of community settings and examine how best to sustain the impact of a healthy lifestyle-healthy aging focused DPP with scalable treatment components over a 24-month period. The Sustain-DPP study will recruit and enroll adults 60 years of age and older, with overweight/obesity (BMI >= 27) and pre-diabetes (either HbA1c of 5.7 to 6.4% inclusive or fasting glucose >=100 but less than 126 mg/dL) (N = 360) from a network of community centers that offer healthy aging services and from community research registries. The intervention program sequence has been designed to align with current Medicare guidelines. First, from 0-6 months, experienced lifestyle coaches will administer a combination of in-person, video and telephone coaching sessions for all participants, at least 25% from ethnic/racial minority groups. Next, individual participants will be randomized (N = 180 per arm; stratified by weight loss of < or ≥ 5% and other demographic factors) to one of two 18-month follow-up conditions delivered as once-a-month telephone sessions only from 6-24 months. The investigators will compare the effects of (1) 30-minute behavioral intervention sessions, which include a Medicare-DPP and healthy lifestyle for healthy aging focus, and (2) 15-minute social support sessions, on measures of weight (the primary outcome) at 12-, 18-, and 24-months. In addition, data will be collected on cardiometabolic, physical activity, physical function, psychosocial, behavioral and other age-sensitive quality of life measures at 12- and 18- and 24-months. Finally, Medicare claims data will be examined for a proportion of the sample regarding medication use, outpatient, inpatient, and emergency visits and enrollment/participation in elder-focused activity programs. This work, if successful, will have immediate potential for DPP-sustainable lifestyle interventions that benefit vulnerable aging individuals and society.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, PreDiabetes, Aging
Keywords
Intervention, Prevention, Weight Management, Physical Activity, Physical Function

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
An initial 16-session Diabetes Prevention Program (DPP), called Group Lifestyle Balance (GLB) and aligned with current Medicare guidelines, will be administered to all enrolled participants primarily through group telephone contact, videos, and workbooks. Subsequently one-half of those enrolled will be randomly assigned to either (1) 30-minute DPP behavior intervention group telephone contact, or (2) 15-minute support group telephone contact for a total of 18 additional follow up months.
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
314 (Actual)

8. Arms, Groups, and Interventions

Arm Title
DPP Plus: 30-minute calls
Arm Type
Active Comparator
Arm Description
Following the 6-month, 16-session, DPP core program, 30-minute group telephone calls will be implemented. Structured behavioral DPP maintenance sessions with a healthy aging focus occur once-per-month from months 7 to 12, and every-two-months from months 13 to 24.
Arm Title
DPP Minimal: 15-minute calls
Arm Type
Placebo Comparator
Arm Description
Following the 6-month, 16-session, DPP core program, 15-minute group telephone calls will be implemented. Social-support sessions occur once-per-month from months 7 to 12, and every-two-months from months 13 to 24.
Intervention Type
Behavioral
Intervention Name(s)
DPP Intensive: 30-minute calls
Other Intervention Name(s)
Behavior Change/Relapse Prevention/Healthy Aging
Intervention Description
Ongoing DPP intervention and behavioral progress review to prevent relapse and improve cardiometabolic and functional health targets as keys to healthy aging.
Intervention Type
Behavioral
Intervention Name(s)
DPP Support: 15-minute calls
Other Intervention Name(s)
Social Support
Intervention Description
No further behavioral intervention materials provided; phone-contacts for mutual social support and accountability
Primary Outcome Measure Information:
Title
Change in bodyweight
Description
percent weight loss
Time Frame
change from baseline bodyweight at 24 months
Secondary Outcome Measure Information:
Title
Change in waist circumference
Description
centimeters
Time Frame
change from baseline waist circumference at 12 months
Title
Change in waist circumference
Description
centimeters
Time Frame
change from baseline waist circumference at 24 months
Title
Change in fasting glucose
Description
mg/dL
Time Frame
change from baseline fasting glucose at 12 months
Title
Change in fasting glucose
Description
mg/dL
Time Frame
change from baseline fasting glucose at 24 months
Title
Change in fasting insulin
Description
pmol/L
Time Frame
change from baseline fasting insulin at 12 months
Title
Change in fasting insulin
Description
pmol/L
Time Frame
change from baseline fasting insulin at 24 months
Title
Change in hemoglobin (HbA1c)
Description
HbA1c percent
Time Frame
change from baseline fasting insulin at 12 months
Title
Change in hemoglobin (HbA1c)
Description
HbA1c percent
Time Frame
change from baseline fasting insulin at 24 months
Title
Change in total cholesterol
Description
mg/dL
Time Frame
change from baseline fasting total cholesterol at 12 months
Title
Change in total cholesterol
Description
mg/dL
Time Frame
change from baseline fasting total cholesterol at 24 months
Title
Change in high-density lipoprotein (HDL)
Description
mg/dL
Time Frame
change from baseline fasting HDL at 12 months
Title
Change in high-density lipoprotein (HDL)
Description
mg/dL
Time Frame
change from baseline fasting HDL at 24 months
Title
Change in low-density lipoprotein (LDL)
Description
mg/dL
Time Frame
change from baseline fasting LDL at 12 months
Title
Change in low-density lipoprotein (LDL)
Description
mg/dL
Time Frame
change from baseline fasting LDL at 24 months
Title
Change in triglycerides
Description
mg/dL
Time Frame
change from baseline fasting triglycerides at 12 months
Title
Change in triglycerides
Description
mg/dL
Time Frame
change from baseline fasting triglycerides at 24 months
Title
Change in systolic blood pressure (SBP)
Description
mmHg
Time Frame
change from baseline SBP at 12 months
Title
Change in systolic blood pressure (SBP)
Description
mmHg
Time Frame
change from baseline SBP at 24 months
Title
Change in diastolic blood pressure (DBP)
Description
mmHg
Time Frame
change from baseline DBP at 12 months
Title
Change in diastolic blood pressure (DBP)
Description
mmHg
Time Frame
change from baseline DBP at 24 months
Title
Change in physical function
Description
Short Physical Performance Battery total score (0-12) includes three function tests (each scored 0-4) and summed. The subtests are (1) gait speed measured in meters/second on a 4-meter walk route; 3 progressive standing balance tests; 5 chair stands. Higher score indicates better physical function.
Time Frame
change from baseline at 12 months
Title
Change in physical function
Description
Short Physical Performance Battery total score (0-12) includes three function tests (each scored 0-4) and summed. The subtests are (1) gait speed measured in meters/second on a 4-meter walk route; 3 progressive standing balance tests; 5 chair stands. Higher score indicates better physical function.
Time Frame
change from baseline at 24 months
Other Pre-specified Outcome Measures:
Title
Change in health related quality of life
Description
Short-form 12-item health status questionnaire produces two scores; a physical component summary score and a mental component summary score. Scores range from 0-100 with higher scores indicating better health related quality of life. Each component score is transformed (standardized) using a mean of 50 and a standard deviation of 10.
Time Frame
change from baseline at 12 months
Title
Change in health related quality of life
Description
Short-form 12-item health status questionnaire produces two scores; a physical component summary score and a mental component summary score. Scores range from 0-100 with higher scores indicating better health related quality of life. Each component score is transformed (standardized) using a mean of 50 and a standard deviation of 10.
Time Frame
change from baseline at 24 months
Title
Change in mood
Description
Center for Epidemiologic Studies Depression scale (score ranges 0-60; higher score indicates greater depressive symptoms)
Time Frame
change from baseline at 12 months
Title
Change in mood
Description
Center for Epidemiologic Studies Depression scale (score ranges 0-60; higher score indicates greater depressive symptoms)
Time Frame
change from baseline at 24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Men and women Ages 60 and older Body mass index (BMI) >= 27 kg/m2 Prediabetes defined as Hemoglobin (HbA1c) >= 5.7 % and <= 6.4 % or fasting glucose of >= 100 mg/dL and less than 126 mg/dL (at either screening or baseline visit) Access to a telephone (for group calls) and to video-player or computer with Internet (to watch session videos and activity videos) Able to travel to one of the community clinics in Southwestern Pennsylvania to participate in the first four in-person intervention sessions and five health assessments at 0, 6, 12, 18, and 24 months Has health care provider permission to participate Exclusion Criteria: Currently diagnosed with diabetes (defined as HbA1c of >= 6.5% at either screening or baseline visit) Currently taking glucose lowering medications or weight loss medications Weight loss of 9 pounds or more in the last six months History of bariatric surgery within the last 2 years Permanently confined to wheelchair Significant cognitive or psychiatric disability that would preclude participation in normal community-based educational activities
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elizabeth M Venditti, PhD
Organizational Affiliation
Univ. Pittsburgh School of Medicine-Dept. Psychiatry
Official's Role
Principal Investigator
Facility Information:
Facility Name
Univ. Pittsburgh School of Medicine-Dept. Psychiatry
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Investigators will follow the guidance of NIDDK on data preparation and sharing policies and insure there is permission to disclose de-identified individual participant-level data collected prior to releasing it to other researchers. In addition, requesting researchers must meet all NIDDK access requirements. Study investigators will maintain strict compliance with Human Research Protections/IRB requirements and use appropriate safeguards before sharing any IPD with other researchers. Within 3 years following final data collection, the investigators will prepare and share the final, completely de-identified dataset (IPD) with NIDDK to be made available to other researchers. However, the investigators will not share other statistical code or data dictionaries.
IPD Sharing Time Frame
3 years from the final data collection of the last participant
IPD Sharing Access Criteria
Investigators will share data through the NIDDK central repository (website shown below)
IPD Sharing URL
http://repository.niddk.nih.gov/home/

Learn more about this trial

Reducing Cardiometabolic Risk and Promoting Functional Health in Older Adults With Obesity and Prediabetes

We'll reach out to this number within 24 hrs